United Services Automobile Association Tricida, Inc. Transaction History

United Services Automobile Association

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$29.87 - $42.22 $1.24 Million - $1.76 Million	-41,609 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$31.16 - $39.46 $571,038 - $723,143	18,326 Added 78.71%	41,609 $1.64 Million
Q4 2018 Feb 13, 2019	SELL	$23.57 - $32.33 $36,887 - $50,596	-1,565 Reduced 6.3%	23,283 $549,000
Q3 2018 Nov 13, 2018	BUY	$22.5 - $39.35 $131,580 - $230,118	5,848 Added 30.78%	24,848 $759,000
Q2 2018 Aug 10, 2018	BUY	$26.0 - $29.9 $494,000 - $568,100	19,000 New	19,000 $568,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.